A nationwide recall of a widely prescribed blood pressure medication has been announced after a quality issue was identified in specific batches of Diovan (valsartan), prompting regulatory action and patient attention across the United States. The recall affects a limited lot of the brand-name drug manufactured by Novartis and distributed after production by Patheon Manufacturing Services.
FDA Announces Voluntary Recall Of Specific Diovan Lot
The U.S. Food and Drug Administration (FDA) reported that Novartis voluntarily initiated the recall on August 4 after identifying a failure related to dissolution specifications. The issue means the affected tablets may not dissolve as expected, potentially affecting how the medication is absorbed by the body after being taken.
The FDA classified the recall as a Class II event on August 7. According to the agency, this classification applies when exposure to a product may cause temporary or medically reversible health effects, or when the likelihood of serious health consequences is considered remote.
The recalled medication is Diovan 160 mg tablets, a prescription treatment containing valsartan, an angiotensin II receptor blocker (ARB). These medications work by blocking a substance in the body that can cause blood vessels to tighten, helping reduce blood pressure and easing strain on the cardiovascular system.
The affected product details provided by the FDA include a 90-tablet bottle labeled “Rx only,” with lot number AV5913C and an expiration date of 06/2027. The agency identified the manufacturer as Patheon Manufacturing Services in North Carolina, with distribution handled by Novartis from its New Jersey office.
© Shutterstock
What Patients Taking Valsartan Should Know
Valsartan is commonly prescribed for people managing high blood pressure and certain heart conditions. The medication belongs to a class of treatments designed to influence the body’s blood vessel regulation system, helping improve circulation and reduce cardiovascular pressure.
The Mayo Clinic explains that valsartan is an angiotensin II receptor blocker that works by “blocking a substance in the body that causes blood vessels to tighten.” The medical organization notes that the medication is used for several conditions involving the heart and blood vessels.
The Mayo Clinic adds:
“Valsartan is used alone or together with other medicines to treat high blood pressure (hypertension) … Valsartan is also used to treat heart failure and left ventricular failure after a heart attack.”
Patients who have been prescribed Diovan should check their medication packaging against the recalled lot information before making any changes. Medical professionals generally advise patients not to stop taking prescription blood pressure medication without guidance from their healthcare provider.
How To Check If Your Medication Is Part Of The Recall
Consumers can identify whether their prescription is included by reviewing the bottle label and comparing the information with the FDA recall announcement. The recall applies only to the specific Diovan 160 mg, 90-tablet product with lot number AV5913C.
The recall does not apply to every version of Diovan or every medication containing valsartan. Different strengths, package sizes, and lot numbers may not be affected by the manufacturing issue.
Patients who discover that they have the recalled product can contact their pharmacist or healthcare provider for instructions on replacement options. Pharmacists can help determine whether an alternative supply is available while ensuring treatment for hypertension or heart conditions continues safely.
The FDA’s announcement provides the official details needed for consumers and healthcare professionals to identify the affected medication. Regulatory recalls allow manufacturers and agencies to address potential quality problems before broader health risks develop.
